This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Mikael Winkler, Ph.D.
CTO & Co-founder at Commit Biologics
Speaker

Profile

Mikael holds a PhD degree in Molecular Biology from Aarhus University in Denmark where he studied the structure and function of membrane proteins. He has extensive experience within structural biology, and his work on cholesterol and auxin transporters has been published in the high impact journals Nature and Cell. Following his PhD, Mikael worked together with the other founders on developing the BiCEā„¢ technology.

Agenda Sessions

  • BiCEā„¢ ā€“ An Antibody Platform to Potentiate Complement Activation for the Treatment of Cancer and Autoimmune Diseases

    ,Ā 8:45am